vs
Alphatec Holdings, Inc.（ATEC）与IBEX Ltd（IBEX）财务数据对比。点击上方公司名可切换其他公司
Alphatec Holdings, Inc.的季度营收约是IBEX Ltd的1.3倍（$212.9M vs $164.2M），IBEX Ltd净利率更高（7.4% vs -10.2%，领先17.6%），Alphatec Holdings, Inc.同比增速更快（20.4% vs 16.7%），Alphatec Holdings, Inc.自由现金流更多（$7.7M vs $-5.1M），过去两年Alphatec Holdings, Inc.的营收复合增速更高（24.0% vs 13.8%）
Alphatec Holdings是一家全球医疗科技企业，专注于研发、生产及销售脊柱外科手术相关的植入物、手术器械与数字化手术平台，服务骨科及神经外科医疗从业者，核心市场覆盖北美、欧洲及亚太主要区域。
IBEX 35是西班牙主要交易所马德里证券交易所的基准股票指数，该指数始创于1992年，由西班牙证券市场集团BME旗下的交易所公司负责计算与管理。它以市值加权编制，涵盖马德里证券交易所流动性最高的35只西班牙股票，每年进行两次成分股调整。
ATEC vs IBEX — 直观对比
营收规模更大
ATEC
是对方的1.3倍
$164.2M
营收增速更快
ATEC
高出3.7%
16.7%
净利率更高
IBEX
高出17.6%
-10.2%
自由现金流更多
ATEC
多$12.8M
$-5.1M
两年增速更快
ATEC
近两年复合增速
13.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $212.9M | $164.2M |
| 净利润 | $-21.7M | $12.2M |
| 毛利率 | 70.2% | — |
| 营业利润率 | -4.1% | 9.3% |
| 净利率 | -10.2% | 7.4% |
| 营收同比 | 20.4% | 16.7% |
| 净利润同比 | 34.8% | 31.8% |
| 每股收益（稀释后） | $-0.15 | $0.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATECIBEX
| Q4 25 | $212.9M | $164.2M | ||
| Q3 25 | $196.5M | $151.2M | ||
| Q2 25 | $185.5M | $147.1M | ||
| Q1 25 | $169.2M | $140.7M | ||
| Q4 24 | $176.8M | $140.7M | ||
| Q3 24 | $150.7M | $129.7M | ||
| Q2 24 | $145.6M | $124.5M | ||
| Q1 24 | $138.5M | $126.8M |
净利润ATECIBEX
| Q4 25 | $-21.7M | $12.2M | ||
| Q3 25 | $-28.6M | $12.0M | ||
| Q2 25 | $-41.1M | $9.6M | ||
| Q1 25 | $-51.9M | $10.5M | ||
| Q4 24 | $-33.3M | $9.3M | ||
| Q3 24 | $-39.6M | $7.5M | ||
| Q2 24 | $-40.7M | $9.8M | ||
| Q1 24 | $-48.5M | $10.3M |
毛利率ATECIBEX
| Q4 25 | 70.2% | — | ||
| Q3 25 | 69.9% | — | ||
| Q2 25 | 69.6% | — | ||
| Q1 25 | 68.6% | — | ||
| Q4 24 | 68.8% | — | ||
| Q3 24 | 68.2% | — | ||
| Q2 24 | 70.5% | — | ||
| Q1 24 | 70.3% | — |
营业利润率ATECIBEX
| Q4 25 | -4.1% | 9.3% | ||
| Q3 25 | -8.1% | 9.1% | ||
| Q2 25 | -7.1% | 8.3% | ||
| Q1 25 | -26.2% | 9.5% | ||
| Q4 24 | -13.5% | 8.5% | ||
| Q3 24 | -22.4% | 7.0% | ||
| Q2 24 | -24.3% | 10.3% | ||
| Q1 24 | -31.3% | 8.9% |
净利率ATECIBEX
| Q4 25 | -10.2% | 7.4% | ||
| Q3 25 | -14.5% | 8.0% | ||
| Q2 25 | -22.2% | 6.5% | ||
| Q1 25 | -30.7% | 7.4% | ||
| Q4 24 | -18.9% | 6.6% | ||
| Q3 24 | -26.3% | 5.8% | ||
| Q2 24 | -27.9% | 7.9% | ||
| Q1 24 | -35.0% | 8.1% |
每股收益（稀释后）ATECIBEX
| Q4 25 | $-0.15 | $0.83 | ||
| Q3 25 | $-0.19 | $0.82 | ||
| Q2 25 | $-0.27 | $0.63 | ||
| Q1 25 | $-0.35 | $0.73 | ||
| Q4 24 | $-0.22 | $0.57 | ||
| Q3 24 | $-0.28 | $0.43 | ||
| Q2 24 | $-0.29 | $0.55 | ||
| Q1 24 | $-0.34 | $0.57 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $160.8M | $15.5M |
| 总债务越低越好 | $565.9M | $594.0K |
| 股东权益账面价值 | $12.4M | $154.5M |
| 总资产 | $791.2M | $295.8M |
| 负债/权益比越低杠杆越低 | 45.54× | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资ATECIBEX
| Q4 25 | $160.8M | $15.5M | ||
| Q3 25 | $155.7M | $22.7M | ||
| Q2 25 | $157.1M | $15.3M | ||
| Q1 25 | $153.2M | $13.0M | ||
| Q4 24 | $138.8M | $20.2M | ||
| Q3 24 | $81.0M | $62.3M | ||
| Q2 24 | $99.8M | $62.7M | ||
| Q1 24 | $144.1M | $50.7M |
总债务ATECIBEX
| Q4 25 | $565.9M | $594.0K | ||
| Q3 25 | $559.7M | $726.0K | ||
| Q2 25 | $553.9M | $796.0K | ||
| Q1 25 | $548.4M | $735.0K | ||
| Q4 24 | $576.2M | $695.0K | ||
| Q3 24 | $527.7M | $802.0K | ||
| Q2 24 | $519.2M | $867.0K | ||
| Q1 24 | $514.4M | $820.0K |
股东权益ATECIBEX
| Q4 25 | $12.4M | $154.5M | ||
| Q3 25 | $11.5M | $143.6M | ||
| Q2 25 | $23.8M | $134.3M | ||
| Q1 25 | $-85.9M | $124.2M | ||
| Q4 24 | $-14.2M | $108.9M | ||
| Q3 24 | $-1.4M | $171.1M | ||
| Q2 24 | $17.1M | $165.8M | ||
| Q1 24 | $37.6M | $159.3M |
总资产ATECIBEX
| Q4 25 | $791.2M | $295.8M | ||
| Q3 25 | $787.2M | $283.9M | ||
| Q2 25 | $790.3M | $273.2M | ||
| Q1 25 | $785.5M | $274.7M | ||
| Q4 24 | $775.7M | $272.5M | ||
| Q3 24 | $745.9M | $306.3M | ||
| Q2 24 | $768.6M | $293.9M | ||
| Q1 24 | $774.6M | $289.6M |
负债/权益比ATECIBEX
| Q4 25 | 45.54× | 0.00× | ||
| Q3 25 | 48.64× | 0.01× | ||
| Q2 25 | 23.30× | 0.01× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | 30.34× | 0.01× | ||
| Q1 24 | 13.70× | 0.01× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.7M | $6.6M |
| 自由现金流经营现金流 - 资本支出 | $7.7M | $-5.1M |
| 自由现金流率自由现金流/营收 | 3.6% | -3.1% |
| 资本支出强度资本支出/营收 | 6.1% | 7.1% |
| 现金转化率经营现金流/净利润 | — | 0.54× |
| 过去12个月自由现金流最近4个季度 | $2.8M | $29.3M |
8季度趋势，按日历期对齐
经营现金流ATECIBEX
| Q4 25 | $20.7M | $6.6M | ||
| Q3 25 | $14.0M | $15.7M | ||
| Q2 25 | $15.5M | $27.9M | ||
| Q1 25 | $-5.0M | $8.8M | ||
| Q4 24 | $10.5M | $1.1M | ||
| Q3 24 | $-5.3M | $7.8M | ||
| Q2 24 | $-11.4M | $17.4M | ||
| Q1 24 | $-38.4M | $11.4M |
自由现金流ATECIBEX
| Q4 25 | $7.7M | $-5.1M | ||
| Q3 25 | $4.8M | $8.0M | ||
| Q2 25 | $5.2M | $22.8M | ||
| Q1 25 | $-15.0M | $3.6M | ||
| Q4 24 | $8.5M | $-3.2M | ||
| Q3 24 | $-21.2M | $4.1M | ||
| Q2 24 | $-45.5M | $15.2M | ||
| Q1 24 | $-69.8M | $9.7M |
自由现金流率ATECIBEX
| Q4 25 | 3.6% | -3.1% | ||
| Q3 25 | 2.4% | 5.3% | ||
| Q2 25 | 2.8% | 15.5% | ||
| Q1 25 | -8.9% | 2.5% | ||
| Q4 24 | 4.8% | -2.3% | ||
| Q3 24 | -14.1% | 3.2% | ||
| Q2 24 | -31.3% | 12.2% | ||
| Q1 24 | -50.4% | 7.7% |
资本支出强度ATECIBEX
| Q4 25 | 6.1% | 7.1% | ||
| Q3 25 | 4.7% | 5.1% | ||
| Q2 25 | 5.6% | 3.5% | ||
| Q1 25 | 5.9% | 3.7% | ||
| Q4 24 | 1.1% | 3.1% | ||
| Q3 24 | 10.5% | 2.8% | ||
| Q2 24 | 23.4% | 1.8% | ||
| Q1 24 | 22.6% | 1.3% |
现金转化率ATECIBEX
| Q4 25 | — | 0.54× | ||
| Q3 25 | — | 1.30× | ||
| Q2 25 | — | 2.91× | ||
| Q1 25 | — | 0.84× | ||
| Q4 24 | — | 0.12× | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 1.77× | ||
| Q1 24 | — | 1.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATEC
暂无分部数据
IBEX
| Transferred Over Time | $147.1M | 90% |
| Transferred At Point In Time | $17.1M | 10% |
